Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;2(4):193-7.
doi: 10.3342/ceo.2009.2.4.193. Epub 2009 Dec 31.

Clinical manifestations of recurrent parotid pleomorphic adenoma

Affiliations

Clinical manifestations of recurrent parotid pleomorphic adenoma

Myung-Whan Suh et al. Clin Exp Otorhinolaryngol. 2009 Dec.

Abstract

Objectives: This study was undertaken to confirm the clinical characteristics of recurrent pleomorphic adenoma (RPA), and to identify those factors that affect the development of malignant transformation (MT) from RPA.

Methods: The medical records of 270 patients, who were operated upon for parotid PA, were retrospectively reviewed. The pathologic specimens of a selected series of 23 patients were reviewed for histologic subtype and microscopic multi-nodularity.

Results: Mean age of initial operation in RPA without MT (RPA(-MT)) group was significantly lower than that of primary PA group. Mean age of the revision operation in RPA with MT (RPA(+MT)) group was significantly greater than that of RPA(-MT) group. Mean interval from operation to recurrence shortened after each revision operation. The risk of MT and additional recurrence increased significantly with recurrence. In RPA(-MT) group tumor recurrence occurred in 21.4% of patients despite a clear resection margin.

Conclusion: The risk factors for MT may be an age of over 45 yr and multiple recurrences. However, younger patients are more at risk of recurrence. A clear resection margin cannot guarantee a cure in RPA, and it seems that parotid pleomorphic adenomas slowly gain malignant characteristics after repeated recurrences.

Keywords: Parotid glancl; Pleomorphic adenoma; Recurrence; Risk factor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Progressive changes in clinical manifestations after multiple recurrences. Duration between revision operations and subsequent recurrences tended to shorten as the number of previous revisions increased (P=0.06). The percentage of patients with a malignant tumor at revision surgery was higher than at initial operation (P=0.04). The general trend toward an increased risk of further recurrence after repeated surgery was significant (P<0.01), despite our finding of a lower risk at the third than at the second operation.

Similar articles

Cited by

References

    1. Hanna EY, Lee S, Fan CY, Suen JY. Benign neoplasms of the salivery glands. In: Cummings CW, Flint PW, editors. Cummings Otolaryngology: Head & Neck Surgery. 4th ed. Philadelphia: Mosby; 2005. pp. 1348–1377.
    1. Suh MW, Hah JH, Lee KB, Kwon SK, Jung YH, Sung MW, et al. Immunohistochemical characteristics of primary and recurrent pleomorphic adenoma. Korean J Head Neck Oncol. 2005 Nov;21(2):146–150.
    1. Junquera L, Alonso D, Sampedro A, Fresno F, Albertos JM, Lopez-Arranz JS. Pleomorphic adenoma of the salivary glands: prospective clinicopathologic and flow cytometric study. Head Neck. 1999 Oct;21(7):652–656. - PubMed
    1. Bankamp DG, Bierhoff E. Proliferative activity in recurrent and non-recurrent pleomorphic adenoma of the salivary glands. Laryngorhinootologie. 1999 Feb;78(2):77–80. - PubMed
    1. Leverstein H, Tiwari RM, Snow GB, van der Wal JE, van der Waal I. The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland: analysis and results in 40 patients. Eur Arch Otorhinolaryngol. 1997;254(7):313–317. - PubMed